In a review of glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer, the median prevalence of the homozygous null genotype was 50% among control subjects in 98 epidemiologic studies (Carlsten et al. 2008). This evidence concerns the gene GSTM1 and lung cancer.